ENSC (Ensysce Biosciences, Inc. Common Stock) Stock Analysis - Politician Trades
Ensysce Biosciences, Inc. Common Stock (ENSC) is a publicly traded Healthcare sector company. As of May 21, 2026, ENSC trades at $0.31 with a market cap of $2.94M and a P/E ratio of -0.08. ENSC moved +3.27% today. Year to date, ENSC is -70.19%; over the trailing twelve months it is -87.19%. Its 52-week range spans $0.23 to $14.67. Rallies surfaces ENSC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded ENSC stock?
Rallies tracks politician and congressional stock disclosures for ENSC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
GOWER BOB G bought 90.29K (~$44.09K) on Mar 2, 2023.
GOWER BOB G bought 270.00K (~$128.98K) on Mar 1, 2023.
GOWER BOB G bought 109.30K (~$53.37K) on Feb 28, 2023.
ENSC Analyst Consensus
ENSC analyst coverage data. Average price target: $0.00.
Common questions about ENSC
Which politicians traded ENSC stock?
Rallies tracks politician and congressional stock disclosures for ENSC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ENSC?
Yes. Rallies tracks politician and congressional stock disclosures for ENSC, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ENSC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ENSC. It does not provide personalized investment advice.